INSIGHTS ON PHARMACEUTICAL INSPECTION

PHARMACEUTICAL INSPECTION SOLUTIONS

  • Bring together contamination control, modular flexibility, leak testing, ergonomic operation, and validation-ready automation to support safer workflows and dependable performance at scale.

  • Until now, inspecting vials and syringes has required two separate machines. Discover a high-quality inspection solution for small batches of syringes and vials on a single machine.

  • The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.

  • See how automated inspection data collection, centralized reporting, real-time monitoring, and secure record management help manufacturers strengthen compliance and improve production visibility.

  • Adapt to shifting production demands with inspection designed for high-mix, low-volume workflows. Maintain consistent quality, reduce downtime, and switch formats quickly while keeping processes efficient.